Stryker Corporation (SYK) Holdings Reduced by Columbia Partners L L C Investment Management

Columbia Partners L L C Investment Management trimmed its position in shares of Stryker Corporation (NYSE:SYK) by 14.1% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,064 shares of the medical technology company’s stock after selling 3,618 shares during the quarter. Columbia Partners L L C Investment Management’s holdings in Stryker Corporation were worth $3,062,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Acrospire Investment Management LLC bought a new stake in shares of Stryker Corporation during the second quarter worth $111,000. Bollard Group LLC lifted its position in shares of Stryker Corporation by 0.4% during the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 3 shares during the last quarter. Motco lifted its position in shares of Stryker Corporation by 50.7% during the second quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 278 shares during the last quarter. Bruderman Asset Management LLC bought a new stake in shares of Stryker Corporation during the second quarter worth $150,000. Finally, James Investment Research Inc. bought a new stake in shares of Stryker Corporation during the second quarter worth $155,000. 74.13% of the stock is owned by institutional investors.

In other Stryker Corporation news, insider David Floyd sold 19,305 shares of the stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $144.56, for a total value of $2,790,730.80. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Lonny J. Carpenter sold 5,000 shares of the stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the sale, the insider now directly owns 88,207 shares in the company, valued at approximately $12,909,976.52. The disclosure for this sale can be found here. Insiders have sold a total of 25,429 shares of company stock valued at $3,686,927 over the last 90 days. 7.40% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION NOTICE: This news story was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://ledgergazette.com/2017/10/10/stryker-corporation-syk-holdings-reduced-by-columbia-partners-l-l-c-investment-management.html.

Stryker Corporation (NYSE:SYK) opened at 145.93 on Tuesday. Stryker Corporation has a one year low of $106.48 and a one year high of $149.23. The firm has a 50-day moving average of $142.49 and a 200-day moving average of $140.20. The company has a market capitalization of $54.59 billion, a P/E ratio of 32.57 and a beta of 0.81.

Stryker Corporation (NYSE:SYK) last announced its earnings results on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.98 billion. During the same period last year, the business posted $1.39 EPS. Stryker Corporation’s revenue for the quarter was up 6.1% on a year-over-year basis. On average, analysts anticipate that Stryker Corporation will post $6.46 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be issued a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s dividend payout ratio (DPR) is 37.95%.

Several research firms have recently weighed in on SYK. Royal Bank Of Canada reiterated a “buy” rating and set a $155.00 target price on shares of Stryker Corporation in a research report on Monday, October 2nd. SunTrust Banks, Inc. reiterated a “buy” rating and set a $161.00 target price on shares of Stryker Corporation in a research report on Monday, October 2nd. BidaskClub upgraded Stryker Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Cowen and Company reiterated a “buy” rating and set a $160.00 target price (up from $150.00) on shares of Stryker Corporation in a research report on Sunday, July 30th. Finally, Zacks Investment Research downgraded Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $146.78.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, in

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Acrospire Investment Management LLC bought a new stake in shares of Stryker Corporation during the second quarter worth $111,000. Bollard Group LLC lifted its position in shares of Stryker Corporation by 0.4% during the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 3 shares during the last quarter. Motco lifted its position in shares of Stryker Corporation by 50.7% during the second quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 278 shares during the last quarter. Bruderman Asset Management LLC bought a new stake in shares of Stryker Corporation during the second quarter worth $150,000. Finally, James Investment Research Inc. bought a new stake in shares of Stryker Corporation during the second quarter worth $155,000. 74.13% of the stock is owned by institutional investors.

In other Stryker Corporation news, insider David Floyd sold 19,305 shares of the stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $144.56, for a total value of $2,790,730.80. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Lonny J. Carpenter sold 5,000 shares of the stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the sale, the insider now directly owns 88,207 shares in the company, valued at approximately $12,909,976.52. The disclosure for this sale can be found here. Insiders have sold a total of 25,429 shares of company stock valued at $3,686,927 over the last 90 days. 7.40% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION NOTICE: This news story was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://ledgergazette.com/2017/10/10/stryker-corporation-syk-holdings-reduced-by-columbia-partners-l-l-c-investment-management.html.

Stryker Corporation (NYSE:SYK) opened at 145.93 on Tuesday. Stryker Corporation has a one year low of $106.48 and a one year high of $149.23. The firm has a 50-day moving average of $142.49 and a 200-day moving average of $140.20. The company has a market capitalization of $54.59 billion, a P/E ratio of 32.57 and a beta of 0.81.

Stryker Corporation (NYSE:SYK) last announced its earnings results on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.98 billion. During the same period last year, the business posted $1.39 EPS. Stryker Corporation’s revenue for the quarter was up 6.1% on a year-over-year basis. On average, analysts anticipate that Stryker Corporation will post $6.46 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be issued a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s dividend payout ratio (DPR) is 37.95%.

Several research firms have recently weighed in on SYK. Royal Bank Of Canada reiterated a “buy” rating and set a $155.00 target price on shares of Stryker Corporation in a research report on Monday, October 2nd. SunTrust Banks, Inc. reiterated a “buy” rating and set a $161.00 target price on shares of Stryker Corporation in a research report on Monday, October 2nd. BidaskClub upgraded Stryker Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Cowen and Company reiterated a “buy” rating and set a $160.00 target price (up from $150.00) on shares of Stryker Corporation in a research report on Sunday, July 30th. Finally, Zacks Investment Research downgraded Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $146.78.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply